Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05964569

Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma

Led by University Hospital Heidelberg · Updated on 2024-01-05

120

Participants Needed

1

Research Sites

261 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Low-grade glioma (LGG) represent typically slowly growing primary brain tumors with world health organization (WHO) grade I or II who affect young adults around their fourth decade. Radiological feature on MRI is a predominantly T2 hyperintense signal, LGG show typically no contrast uptake. Radiotherapy plays an important role in the treatment of LGG. However, not least because of the good prognosis with long term survivorship the timing of radiotherapy has been discussed controversially. In order to avoid long term sequelae such as neurocognitive impairment, malignant transformation or secondary neoplasms initiation was often postponed as long as possible

CONDITIONS

Official Title

Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age > 18 years
  • Histologically proven low-grade glioma
  • Indication for definitive or adjuvant radiotherapy
  • Ability to understand character and personal consequences of the clinical trial
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Previous cerebral irradiation
  • Contraindication for contrast-enhanced MRI
  • Neurofibromatosis
  • Participation in another clinical trial with competing objectives

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Radiotherapy, University of Heidelberg

Heidelberg, Germany, 69120

Actively Recruiting

Loading map...

Research Team

S

Semi Harrabi, MD

CONTACT

A

Adriane Lentz-Hommertgen, Phd

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here